APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liquid Biopsy Products

Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.

This report mainly covers the Liquid Biopsy Products product type by technology (circulating Tumor Cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (or exosomes)), by sample type (blood, urine and other bio fluids (Tissue fluids and Saliva based)), while we can also offer any product survey report related to the liquid biopsy products industry chain.

Selected research

Market Analysis & Forecast

Global Liquid Biopsy Products Market Analysis and Forecast 2026-2032

1 January 2026199 pages

Choose your research edition.

Industry ResearchLiquid Biopsy Products Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Liquid Biopsy Products Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Liquid Biopsy Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liquid Biopsy Products Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Liquid Biopsy Products Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.

This report mainly covers the Liquid Biopsy Products product type by technology (circulating Tumor Cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (or exosomes)), by sample type (blood, urine and other bio fluids (Tissue fluids and Saliva based)), while we can also offer any product survey report related to the liquid biopsy products industry chain.

The major players in global Liquid Biopsy Products market include RainDanceTechnologies, Biocartis, Qiagen, etc. The top 3 players occupy about 15% shares of the global market. North America is the main market. CTCs is the main type, with a share about 65%. Blood Sample is the main application, which holds a share about 90%.

Read the full market overview

Report Includes

This report presents an overview of global market for Liquid Biopsy Products, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Liquid Biopsy Products, also provides the revenue of main regions and countries. Of the upcoming market potential for Liquid Biopsy Products, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liquid Biopsy Products revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Liquid Biopsy Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Liquid Biopsy Products revenue, projected growth trends, production technology, application and end-user industry.

Liquid Biopsy Products Segment by Company

RainDanceTechnologies

Biocartis

Qiagen

Guardant Health

MDxHealth

Pathway Genomics

NeoGenomics Laboraories

Sysmex Inostics

Cynvenio

Menarini Silicon Biosystems

Adaptive Biotechnologies

Biocept

Angle plc

Liquid Biopsy Products Segment by Type

CTCs

ctDNA

Exosomes

Liquid Biopsy Products Segment by Application

Blood Sample

Urine Sample

Other Bio Fluids

Liquid Biopsy Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liquid Biopsy Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liquid Biopsy Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liquid Biopsy Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Liquid Biopsy Products in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Liquid Biopsy Products company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liquid Biopsy Products revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Liquid Biopsy Products Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. CTCs Major Player Table 3. ctDNA Major Player Table 4. Exosomes Major Player Table 5. Global Liquid Biopsy Products Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Blood Sample Major Player Table 7. Urine Sample Major Player Table 8. Other Bio Fluids Major Player Table 9. Liquid Biopsy Products Industry Trends Table 10. Liquid Biopsy Products Industry Drivers Table 11. Liquid Biopsy Products Industry Opportunities and Challenges Table 12. Liquid Biopsy Products Industry Restraints Table 13. Global Liquid Biopsy Products Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Liquid Biopsy Products Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Liquid Biopsy Products Market Share by Region (2021-2026) Table 16. Global Liquid Biopsy Products Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Liquid Biopsy Products Market Share by Region (2027-2032) Table 18. Global Liquid Biopsy Products Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Liquid Biopsy Products Revenue Market Share by Players (2021-2026) Table 20. Global Liquid Biopsy Products Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Liquid Biopsy Products Key Players Headquarters & Area Served Table 22. Global Liquid Biopsy Products Players, Product Type & Application Table 23. Global Liquid Biopsy Products Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Liquid Biopsy Products by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Liquid Biopsy Products Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Liquid Biopsy Products Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Liquid Biopsy Products Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Liquid Biopsy Products Revenue Market Share by Type (2021-2026) Table 30. Global Liquid Biopsy Products Revenue Market Share by Type (2027-2032) Table 31. Global Liquid Biopsy Products Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Liquid Biopsy Products Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Liquid Biopsy Products Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Liquid Biopsy Products Revenue Market Share by Application (2021-2026) Table 35. Global Liquid Biopsy Products Revenue Market Share by Application (2027-2032) Table 36. RainDanceTechnologies Company Information Table 37. RainDanceTechnologies Business Overview Table 38. RainDanceTechnologies Liquid Biopsy Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. RainDanceTechnologies Liquid Biopsy Products Product Portfolio Table 40. RainDanceTechnologies Recent Development Table 41. Biocartis Company Information Table 42. Biocartis Business Overview Table 43. Biocartis Liquid Biopsy Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Biocartis Liquid Biopsy Products Product Portfolio Table 45. Biocartis Recent Development Table 46. Qiagen Company Information Table 47. Qiagen Business Overview Table 48. Qiagen Liquid Biopsy Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Qiagen Liquid Biopsy Products Product Portfolio Table 50. Qiagen Recent Development Table 51. Guardant Health Company Information Table 52. Guardant Health Business Overview Table 53. Guardant Health Liquid Biopsy Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Guardant Health Liquid Biopsy Products Product Portfolio Table 55. Guardant Health Recent Development Table 56. MDxHealth Company Information Table 57. MDxHealth Business Overview Table 58. MDxHealth Liquid Biopsy Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. MDxHealth Liquid Biopsy Products Product Portfolio Table 60. MDxHealth Recent Development Table 61. Pathway Genomics Company Information Table 62. Pathway Genomics Business Overview Table 63. Pathway Genomics Liquid Biopsy Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Pathway Genomics Liquid Biopsy Products Product Portfolio Table 65. Pathway Genomics Recent Development Table 66. NeoGenomics Laboraories Company Information Table 67. NeoGenomics Laboraories Business Overview Table 68. NeoGenomics Laboraories Liquid Biopsy Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. NeoGenomics Laboraories Liquid Biopsy Products Product Portfolio Table 70. NeoGenomics Laboraories Recent Development Table 71. Sysmex Inostics Company Information Table 72. Sysmex Inostics Business Overview Table 73. Sysmex Inostics Liquid Biopsy Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Sysmex Inostics Liquid Biopsy Products Product Portfolio Table 75. Sysmex Inostics Recent Development Table 76. Cynvenio Company Information Table 77. Cynvenio Business Overview Table 78. Cynvenio Liquid Biopsy Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Cynvenio Liquid Biopsy Products Product Portfolio Table 80. Cynvenio Recent Development Table 81. Menarini Silicon Biosystems Company Information Table 82. Menarini Silicon Biosystems Business Overview Table 83. Menarini Silicon Biosystems Liquid Biopsy Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Menarini Silicon Biosystems Liquid Biopsy Products Product Portfolio Table 85. Menarini Silicon Biosystems Recent Development Table 86. Adaptive Biotechnologies Company Information Table 87. Adaptive Biotechnologies Business Overview Table 88. Adaptive Biotechnologies Liquid Biopsy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Adaptive Biotechnologies Liquid Biopsy Products Product Portfolio Table 90. Adaptive Biotechnologies Recent Development Table 91. Biocept Company Information Table 92. Biocept Business Overview Table 93. Biocept Liquid Biopsy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Biocept Liquid Biopsy Products Product Portfolio Table 95. Biocept Recent Development Table 96. Angle plc Company Information Table 97. Angle plc Business Overview Table 98. Angle plc Liquid Biopsy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Angle plc Liquid Biopsy Products Product Portfolio Table 100. Angle plc Recent Development Table 101. North America Liquid Biopsy Products Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Liquid Biopsy Products Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Liquid Biopsy Products Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Liquid Biopsy Products Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Liquid Biopsy Products Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Liquid Biopsy Products Revenue by Country (2021-2026) & (US$ Million) Table 107. North America Liquid Biopsy Products Revenue by Country (US$ Million) & (2027-2032) Table 108. Europe Liquid Biopsy Products Revenue by Type (2021-2026) & (US$ Million) Table 109. Europe Liquid Biopsy Products Revenue by Type (2027-2032) & (US$ Million) Table 110. Europe Liquid Biopsy Products Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Liquid Biopsy Products Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Liquid Biopsy Products Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Europe Liquid Biopsy Products Revenue by Country (2021-2026) & (US$ Million) Table 114. Europe Liquid Biopsy Products Revenue by Country (US$ Million) & (2027-2032) Table 115. China Liquid Biopsy Products Revenue by Type (2021-2026) & (US$ Million) Table 116. China Liquid Biopsy Products Revenue by Type (2027-2032) & (US$ Million) Table 117. China Liquid Biopsy Products Revenue by Application (2021-2026) & (US$ Million) Table 118. China Liquid Biopsy Products Revenue by Application (2027-2032) & (US$ Million) Table 119. Asia Liquid Biopsy Products Revenue by Type (2021-2026) & (US$ Million) Table 120. Asia Liquid Biopsy Products Revenue by Type (2027-2032) & (US$ Million) Table 121. Asia Liquid Biopsy Products Revenue by Application (2021-2026) & (US$ Million) Table 122. Asia Liquid Biopsy Products Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Liquid Biopsy Products Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Asia Liquid Biopsy Products Revenue by Region (US$ Million) & (2021-2026) Table 125. Asia Liquid Biopsy Products Revenue by Region (US$ Million) & (2027-2032) Table 126. SAMEA Liquid Biopsy Products Revenue by Type (2021-2026) & (US$ Million) Table 127. SAMEA Liquid Biopsy Products Revenue by Type (2027-2032) & (US$ Million) Table 128. SAMEA Liquid Biopsy Products Revenue by Application (2021-2026) & (US$ Million) Table 129. SAMEA Liquid Biopsy Products Revenue by Application (2027-2032) & (US$ Million) Table 130. SAMEA Liquid Biopsy Products Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. SAMEA Liquid Biopsy Products Revenue by Country (2021-2026) & (US$ Million) Table 132. SAMEA Liquid Biopsy Products Revenue by Country (US$ Million) & (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Liquid Biopsy Products Image Figure 2. Global Liquid Biopsy Products Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liquid Biopsy Products Market Size Share 2021 VS 2025 VS 2032 Figure 4. CTCs Image Figure 5. ctDNA Image Figure 6. Exosomes Image Figure 7. Global Liquid Biopsy Products Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Liquid Biopsy Products Market Size Share 2021 VS 2025 VS 2032 Figure 9. Blood Sample Image Figure 10. Urine Sample Image Figure 11. Other Bio Fluids Image Figure 12. Global Liquid Biopsy Products Market Size (US$ Million) & (2021-2032) Figure 13. Global Liquid Biopsy Products Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Liquid Biopsy Products Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Liquid Biopsy Products Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Liquid Biopsy Products Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Liquid Biopsy Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Liquid Biopsy Products Revenue Market Share by Type (2021-2032) Figure 20. Global Liquid Biopsy Products Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Liquid Biopsy Products Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Liquid Biopsy Products Revenue Market Share by Application (2021-2032) Figure 23. North America Liquid Biopsy Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Liquid Biopsy Products Revenue Share by Type (2021-2032) Figure 25. North America Liquid Biopsy Products Revenue Share by Application (2021-2032) Figure 26. North America Liquid Biopsy Products Revenue Share by Country (2021-2032) Figure 27. United States Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Liquid Biopsy Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Liquid Biopsy Products Revenue Share by Type (2021-2032) Figure 32. Europe Liquid Biopsy Products Revenue Share by Application (2021-2032) Figure 33. Europe Liquid Biopsy Products Revenue Share by Country (2021-2032) Figure 34. Germany Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Liquid Biopsy Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Liquid Biopsy Products Revenue Share by Type (2021-2032) Figure 44. China Liquid Biopsy Products Revenue Share by Application (2021-2032) Figure 45. Asia Liquid Biopsy Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Liquid Biopsy Products Revenue Share by Type (2021-2032) Figure 47. Asia Liquid Biopsy Products Revenue Share by Application (2021-2032) Figure 48. Asia Liquid Biopsy Products Revenue Share by Region (2021-2032) Figure 49. Japan Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Liquid Biopsy Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Liquid Biopsy Products Revenue Share by Type (2021-2032) Figure 57. SAMEA Liquid Biopsy Products Revenue Share by Application (2021-2032) Figure 58. SAMEA Liquid Biopsy Products Revenue Share by Country (2021-2032) Figure 59. Brazil Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Liquid Biopsy Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • CTCs
  • ctDNA
  • Exosomes
Applications
  • Blood Sample
  • Urine Sample
  • Other Bio Fluids
Companies covered
  • RainDanceTechnologies
  • Biocartis
  • Qiagen
  • Guardant Health
  • MDxHealth
  • Pathway Genomics
  • NeoGenomics Laboraories
  • Sysmex Inostics
  • Cynvenio
  • Menarini Silicon Biosystems
  • Adaptive Biotechnologies
  • Biocept
  • Angle plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Liquid Biopsy Products Market by Type
  3. 1.2.1 Global Liquid Biopsy Products Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 CTCs
  5. 1.2.3 ctDNA
  6. 1.2.4 Exosomes
  7. 1.3 Liquid Biopsy Products Market by Application
  8. 1.3.1 Global Liquid Biopsy Products Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Blood Sample
  10. 1.3.3 Urine Sample
  11. 1.3.4 Other Bio Fluids
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Liquid Biopsy Products Market Dynamics
  1. 2.1 Liquid Biopsy Products Industry Trends
  2. 2.2 Liquid Biopsy Products Industry Drivers
  3. 2.3 Liquid Biopsy Products Industry Opportunities and Challenges
  4. 2.4 Liquid Biopsy Products Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Liquid Biopsy Products Market Perspective (2021-2032)
  2. 3.2 Global Liquid Biopsy Products Growth Trends by Region
  3. 3.2.1 Global Liquid Biopsy Products Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Liquid Biopsy Products Market Size by Region (2021-2026)
  5. 3.2.3 Global Liquid Biopsy Products Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Liquid Biopsy Products Revenue by Players
  2. 4.1.1 Global Liquid Biopsy Products Revenue by Players (2021-2026)
  3. 4.1.2 Global Liquid Biopsy Products Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Liquid Biopsy Products Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Liquid Biopsy Products Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Liquid Biopsy Products Key Players Headquarters & Area Served
  7. 4.4 Global Liquid Biopsy Products Players, Product Type & Application
  8. 4.5 Global Liquid Biopsy Products Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Liquid Biopsy Products Market CR5 and HHI
  11. 4.6.3 2025 Liquid Biopsy Products Tier 1, Tier 2, and Tier 3
5 Liquid Biopsy Products Market Size by Type
  1. 5.1 Global Liquid Biopsy Products Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Liquid Biopsy Products Revenue by Type (2021-2032)
  3. 5.3 Global Liquid Biopsy Products Revenue Market Share by Type (2021-2032)
6 Liquid Biopsy Products Market Size by Application
  1. 6.1 Global Liquid Biopsy Products Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Liquid Biopsy Products Revenue by Application (2021-2032)
  3. 6.3 Global Liquid Biopsy Products Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 RainDanceTechnologies
  2. 7.1.1 RainDanceTechnologies Company Information
  3. 7.1.2 RainDanceTechnologies Business Overview
  4. 7.1.3 RainDanceTechnologies Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  5. 7.1.4 RainDanceTechnologies Liquid Biopsy Products Product Portfolio
  6. 7.1.5 RainDanceTechnologies Recent Developments
  7. 7.2 Biocartis
  8. 7.2.1 Biocartis Company Information
  9. 7.2.2 Biocartis Business Overview
  10. 7.2.3 Biocartis Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Biocartis Liquid Biopsy Products Product Portfolio
  12. 7.2.5 Biocartis Recent Developments
  13. 7.3 Qiagen
  14. 7.3.1 Qiagen Company Information
  15. 7.3.2 Qiagen Business Overview
  16. 7.3.3 Qiagen Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Qiagen Liquid Biopsy Products Product Portfolio
  18. 7.3.5 Qiagen Recent Developments
  19. 7.4 Guardant Health
  20. 7.4.1 Guardant Health Company Information
  21. 7.4.2 Guardant Health Business Overview
  22. 7.4.3 Guardant Health Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Guardant Health Liquid Biopsy Products Product Portfolio
  24. 7.4.5 Guardant Health Recent Developments
  25. 7.5 MDxHealth
  26. 7.5.1 MDxHealth Company Information
  27. 7.5.2 MDxHealth Business Overview
  28. 7.5.3 MDxHealth Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  29. 7.5.4 MDxHealth Liquid Biopsy Products Product Portfolio
  30. 7.5.5 MDxHealth Recent Developments
  31. 7.6 Pathway Genomics
  32. 7.6.1 Pathway Genomics Company Information
  33. 7.6.2 Pathway Genomics Business Overview
  34. 7.6.3 Pathway Genomics Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Pathway Genomics Liquid Biopsy Products Product Portfolio
  36. 7.6.5 Pathway Genomics Recent Developments
  37. 7.7 NeoGenomics Laboraories
  38. 7.7.1 NeoGenomics Laboraories Company Information
  39. 7.7.2 NeoGenomics Laboraories Business Overview
  40. 7.7.3 NeoGenomics Laboraories Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  41. 7.7.4 NeoGenomics Laboraories Liquid Biopsy Products Product Portfolio
  42. 7.7.5 NeoGenomics Laboraories Recent Developments
  43. 7.8 Sysmex Inostics
  44. 7.8.1 Sysmex Inostics Company Information
  45. 7.8.2 Sysmex Inostics Business Overview
  46. 7.8.3 Sysmex Inostics Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Sysmex Inostics Liquid Biopsy Products Product Portfolio
  48. 7.8.5 Sysmex Inostics Recent Developments
  49. 7.9 Cynvenio
  50. 7.9.1 Cynvenio Company Information
  51. 7.9.2 Cynvenio Business Overview
  52. 7.9.3 Cynvenio Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Cynvenio Liquid Biopsy Products Product Portfolio
  54. 7.9.5 Cynvenio Recent Developments
  55. 7.10 Menarini Silicon Biosystems
  56. 7.10.1 Menarini Silicon Biosystems Company Information
  57. 7.10.2 Menarini Silicon Biosystems Business Overview
  58. 7.10.3 Menarini Silicon Biosystems Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Menarini Silicon Biosystems Liquid Biopsy Products Product Portfolio
  60. 7.10.5 Menarini Silicon Biosystems Recent Developments
  61. 7.11 Adaptive Biotechnologies
  62. 7.11.1 Adaptive Biotechnologies Company Information
  63. 7.11.2 Adaptive Biotechnologies Business Overview
  64. 7.11.3 Adaptive Biotechnologies Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Adaptive Biotechnologies Liquid Biopsy Products Product Portfolio
  66. 7.11.5 Adaptive Biotechnologies Recent Developments
  67. 7.12 Biocept
  68. 7.12.1 Biocept Company Information
  69. 7.12.2 Biocept Business Overview
  70. 7.12.3 Biocept Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Biocept Liquid Biopsy Products Product Portfolio
  72. 7.12.5 Biocept Recent Developments
  73. 7.13 Angle plc
  74. 7.13.1 Angle plc Company Information
  75. 7.13.2 Angle plc Business Overview
  76. 7.13.3 Angle plc Liquid Biopsy Products Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Angle plc Liquid Biopsy Products Product Portfolio
  78. 7.13.5 Angle plc Recent Developments
8 North America
  1. 8.1 North America Liquid Biopsy Products Revenue (2021-2032)
  2. 8.2 North America Liquid Biopsy Products Revenue by Type (2021-2032)
  3. 8.2.1 North America Liquid Biopsy Products Revenue by Type (2021-2026)
  4. 8.2.2 North America Liquid Biopsy Products Revenue by Type (2027-2032)
  5. 8.3 North America Liquid Biopsy Products Revenue Share by Type (2021-2032)
  6. 8.4 North America Liquid Biopsy Products Revenue by Application (2021-2032)
  7. 8.4.1 North America Liquid Biopsy Products Revenue by Application (2021-2026)
  8. 8.4.2 North America Liquid Biopsy Products Revenue by Application (2027-2032)
  9. 8.5 North America Liquid Biopsy Products Revenue Share by Application (2021-2032)
  10. 8.6 North America Liquid Biopsy Products Revenue by Country
  11. 8.6.1 North America Liquid Biopsy Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Liquid Biopsy Products Revenue by Country (2021-2026)
  13. 8.6.3 North America Liquid Biopsy Products Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Liquid Biopsy Products Revenue (2021-2032)
  2. 9.2 Europe Liquid Biopsy Products Revenue by Type (2021-2032)
  3. 9.2.1 Europe Liquid Biopsy Products Revenue by Type (2021-2026)
  4. 9.2.2 Europe Liquid Biopsy Products Revenue by Type (2027-2032)
  5. 9.3 Europe Liquid Biopsy Products Revenue Share by Type (2021-2032)
  6. 9.4 Europe Liquid Biopsy Products Revenue by Application (2021-2032)
  7. 9.4.1 Europe Liquid Biopsy Products Revenue by Application (2021-2026)
  8. 9.4.2 Europe Liquid Biopsy Products Revenue by Application (2027-2032)
  9. 9.5 Europe Liquid Biopsy Products Revenue Share by Application (2021-2032)
  10. 9.6 Europe Liquid Biopsy Products Revenue by Country
  11. 9.6.1 Europe Liquid Biopsy Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Liquid Biopsy Products Revenue by Country (2021-2026)
  13. 9.6.3 Europe Liquid Biopsy Products Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Liquid Biopsy Products Revenue (2021-2032)
  2. 10.2 China Liquid Biopsy Products Revenue by Type (2021-2032)
  3. 10.2.1 China Liquid Biopsy Products Revenue by Type (2021-2026)
  4. 10.2.2 China Liquid Biopsy Products Revenue by Type (2027-2032)
  5. 10.3 China Liquid Biopsy Products Revenue Share by Type (2021-2032)
  6. 10.4 China Liquid Biopsy Products Revenue by Application (2021-2032)
  7. 10.4.1 China Liquid Biopsy Products Revenue by Application (2021-2026)
  8. 10.4.2 China Liquid Biopsy Products Revenue by Application (2027-2032)
  9. 10.5 China Liquid Biopsy Products Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Liquid Biopsy Products Revenue (2021-2032)
  2. 11.2 Asia Liquid Biopsy Products Revenue by Type (2021-2032)
  3. 11.2.1 Asia Liquid Biopsy Products Revenue by Type (2021-2026)
  4. 11.2.2 Asia Liquid Biopsy Products Revenue by Type (2027-2032)
  5. 11.3 Asia Liquid Biopsy Products Revenue Share by Type (2021-2032)
  6. 11.4 Asia Liquid Biopsy Products Revenue by Application (2021-2032)
  7. 11.4.1 Asia Liquid Biopsy Products Revenue by Application (2021-2026)
  8. 11.4.2 Asia Liquid Biopsy Products Revenue by Application (2027-2032)
  9. 11.5 Asia Liquid Biopsy Products Revenue Share by Application (2021-2032)
  10. 11.6 Asia Liquid Biopsy Products Revenue by Country
  11. 11.6.1 Asia Liquid Biopsy Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Liquid Biopsy Products Revenue by Country (2021-2026)
  13. 11.6.3 Asia Liquid Biopsy Products Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Liquid Biopsy Products Revenue (2021-2032)
  2. 12.2 SAMEA Liquid Biopsy Products Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Liquid Biopsy Products Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Liquid Biopsy Products Revenue by Type (2027-2032)
  5. 12.3 SAMEA Liquid Biopsy Products Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Liquid Biopsy Products Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Liquid Biopsy Products Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Liquid Biopsy Products Revenue by Application (2027-2032)
  9. 12.5 SAMEA Liquid Biopsy Products Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Liquid Biopsy Products Revenue by Country
  11. 12.6.1 SAMEA Liquid Biopsy Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Liquid Biopsy Products Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Liquid Biopsy Products Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst